FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a later inspection.
483 Nostrum Labs Aug 2003

483 Nostrum Labs Aug 2003

Shirley Berryman FDA, Chilton Ng FDA$119.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 22 Aug 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Aug 2003
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart